Gut-Liver Axis: Modulating the Gut Microbiota and Its Metabolic Products as a Potential Therapeutic Strategy for the Treatment of Hepatic Ischemia-Reperfusion Injury

Jiahao Wang, Yali Yun, Xunan Dong, Xulong Wang, Haizhong Ma, Qi Fang, Juan Xia, Pengxian Tao, Dongzhi Zhang

PDF(3092 KB)
For Authors|For Editors|For Reviewers
PDF(3092 KB)
Discovery Medicine ›› 2024, Vol. 36 ›› Issue (189) : 1955-1972. DOI: 10.24976/Discov.Med.202436189.181
Review

Gut-Liver Axis: Modulating the Gut Microbiota and Its Metabolic Products as a Potential Therapeutic Strategy for the Treatment of Hepatic Ischemia-Reperfusion Injury

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 36(189): 1955-1972 https://doi.org/10.24976/Discov.Med.202436189.181

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3092 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2024.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.

    • /

    〈 〉